Higher-than-expected claims underline the need for tailored coverage and expanded facultative capacity to help safeguard the critical semiconductor supply chain.
Industry leaders call for greater transparency, enhanced claims oversight, and expanded preventive care, as rising medical costs drive up policyholders’ premiums and insurers’ loss ratios.
New policy addresses management liability needs unique to life sciences, biotech, and pharmaceutical firms and is specifically designed for the R&D ecosystem.
